Alfred Hansel
Director Ejecutivo en oncgnostics GmbH .
Perfil
Alfred Hansel is the founder and Chief Executive Officer of oncgnostics GmbH, a company founded in 2012.
He holds a doctorate degree from the University of Freiburg and an undergraduate degree from Friedrich-Alexander University of Erlangen-Nuremberg.
Cargos activos de Alfred Hansel
| Empresas | Cargo | Inicio |
|---|---|---|
oncgnostics GmbH
 oncgnostics GmbH Medical SpecialtiesHealth Technology oncgnostics GmbH offers cervical cancer diagnostic products and services. It engages in applying tumor-specific DNA methylation markers for cancer diagnosis and screening. The firm develops, based on proprietary epigenetic biomarkers, molecular in vitro diagnostic tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company was founded by Matthias Dürst, Kerstin Brox, Martina Schmitz and Alfred Hansel in February 2012 and is headquartered in Jena, Germany. | Director Ejecutivo | 01/02/2012 |
Formación de Alfred Hansel.
| Friedrich-Alexander University of Erlangen-Nuremberg | Undergraduate Degree |
| University of Freiburg | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
oncgnostics GmbH
oncgnostics GmbH Medical SpecialtiesHealth Technology oncgnostics GmbH offers cervical cancer diagnostic products and services. It engages in applying tumor-specific DNA methylation markers for cancer diagnosis and screening. The firm develops, based on proprietary epigenetic biomarkers, molecular in vitro diagnostic tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company was founded by Matthias Dürst, Kerstin Brox, Martina Schmitz and Alfred Hansel in February 2012 and is headquartered in Jena, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Alfred Hansel
